Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

Clinical trial NCT00570011 · COMPLETED

Trial details

NCT number: NCT00570011
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 1997-06-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.